JP2022543826A5 - - Google Patents

Info

Publication number
JP2022543826A5
JP2022543826A5 JP2022507487A JP2022507487A JP2022543826A5 JP 2022543826 A5 JP2022543826 A5 JP 2022543826A5 JP 2022507487 A JP2022507487 A JP 2022507487A JP 2022507487 A JP2022507487 A JP 2022507487A JP 2022543826 A5 JP2022543826 A5 JP 2022543826A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
chem
integer
range
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022507487A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022543826A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/072137 external-priority patent/WO2021023817A1/en
Publication of JP2022543826A publication Critical patent/JP2022543826A/ja
Publication of JP2022543826A5 publication Critical patent/JP2022543826A5/ja
Withdrawn legal-status Critical Current

Links

JP2022507487A 2019-08-07 2020-08-06 Pyy化合物とn-(8-(2-ヒドロキシベンゾイル)アミノ)カプリル酸の塩とを含む固形組成物 Withdrawn JP2022543826A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19190571.0 2019-08-07
EP19190571 2019-08-07
PCT/EP2020/072137 WO2021023817A1 (en) 2019-08-07 2020-08-06 Solid composition comprising a pyy compound and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid

Publications (2)

Publication Number Publication Date
JP2022543826A JP2022543826A (ja) 2022-10-14
JP2022543826A5 true JP2022543826A5 (cg-RX-API-DMAC7.html) 2023-07-31

Family

ID=67587403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022507487A Withdrawn JP2022543826A (ja) 2019-08-07 2020-08-06 Pyy化合物とn-(8-(2-ヒドロキシベンゾイル)アミノ)カプリル酸の塩とを含む固形組成物

Country Status (6)

Country Link
US (1) US20220280611A1 (cg-RX-API-DMAC7.html)
EP (1) EP4009957B1 (cg-RX-API-DMAC7.html)
JP (1) JP2022543826A (cg-RX-API-DMAC7.html)
CN (1) CN114206375A (cg-RX-API-DMAC7.html)
ES (1) ES2969534T3 (cg-RX-API-DMAC7.html)
WO (1) WO2021023817A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4433093A1 (en) 2021-11-15 2024-09-25 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
EP4299057A1 (en) 2022-06-30 2024-01-03 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
EP4180060A1 (en) 2021-11-15 2023-05-17 Adocia Solid compositions comprising a peptide or a protein and an acylated amino acid
EP4299052A1 (en) 2022-06-30 2024-01-03 Adocia Solid compositions comprising a peptide or a protein and a permeation enhancer
EP4299071A1 (en) 2022-07-01 2024-01-03 Adocia Compositions comprising a peptide or a protein and an acylated amino acid
JP2025526148A (ja) * 2022-08-18 2025-08-07 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 長時間作用型glp-1/グルカゴン受容体アゴニスト及びnpy2受容体アゴニストを含む組合せ治療

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05012278A (es) * 2003-05-14 2006-02-10 Emisphere Tech Inc Composiciones para suministrar peptido yy y combatientes pyy.
GB0504857D0 (en) * 2005-03-09 2005-04-13 Imp College Innovations Ltd Novel compounds and their effects on feeding behaviour
MX377589B (es) * 2010-12-16 2025-03-10 Novo Nordisk As Composiciones sólidas que comprenden agonista de glp-1 y sal del ácido n-(8-(2-hidroxibenzoil)amino)caprílico.
KR102072202B1 (ko) * 2012-03-22 2020-01-31 노보 노르디스크 에이/에스 Glp-1 펩티드의 조성물 및 그것의 제조
WO2015071355A1 (en) * 2013-11-15 2015-05-21 Novo Nordisk A/S Selective pyy compounds and uses thereof
US10583172B2 (en) * 2013-11-15 2020-03-10 Novo Nordisk A/S HPYY(1-36) having a beta-homoarginine substitution at position 35
WO2016124687A1 (en) * 2015-02-04 2016-08-11 Novo Nordisk A/S Selective pyy compounds and uses thereof
MX392572B (es) * 2015-06-12 2025-03-24 Novo Nordisk As Compuestos del péptido yy (pyy) selectivos y sus usos.

Similar Documents

Publication Publication Date Title
US12478617B2 (en) Lipidated peptide inhibitors of interleukin-23 receptor
RU2470016C2 (ru) Производное бипиразола
JP5749879B2 (ja) ペプチドyyおよびペプチドyyアゴニストの送達用組成物
JP2005530732A5 (cg-RX-API-DMAC7.html)
US20090163408A1 (en) Salicylanilides enhance oral delivery of therapeutic peptides
PE20231841A1 (es) Coagonistas de los receptores glp-1 y gip adecuados para el suministro oral
JP6547034B2 (ja) ペプチドの使用
JP2023071869A (ja) グルカゴンおよびglp-1受容体の長時間作用型コアゴニスト
AU2019323697B2 (en) Acylated calcitonin mimetics
US20100260755A1 (en) Ibudilast and immunomodulators combination
RU2012128547A (ru) Дважды ацилированные производные glp-1
MX355361B (es) Derivados de peptido 1 tipo glucagon (glp-1) doblemente acilados.
JP2010512753A5 (cg-RX-API-DMAC7.html)
JP2010515686A5 (cg-RX-API-DMAC7.html)
CN101203531A (zh) 修饰的pyy(3-36)多肽及它们对进食行为的影响
US20180280480A1 (en) Compositions and peptides having dual glp-1r and glp-2r agonist activity
AU2004241242A1 (en) Compositions for delivering peptide YY and PYY agonists
JP2004521123A5 (cg-RX-API-DMAC7.html)
JP2023500032A5 (cg-RX-API-DMAC7.html)
EP1945243B1 (en) Use of calcitonin for the treatment of ra
WO2014023923A2 (fr) Traitement de l'arthrose par les hormones incrétines ou leurs analogues
CN107847452A (zh) 应答选择性C5a激动剂EP67的构象稳定类似物
JP2023508349A (ja) グルカゴン受容体およびglp-1受容体のステープルトリアゾールコアゴニスト
US12378294B2 (en) IL-4 derived peptides for use in the treatment of obesity
JP3806444B2 (ja) ウイルス感染に対する宿主防御機構の刺激